Hyderabad Telangana, India

Dattatrey Kokane

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dattatrey Kokane: Innovator in Pharmaceutical Processes

Introduction

Dattatrey Kokane is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. His work is characterized by a focus on improving existing methodologies to enhance efficiency and effectiveness.

Latest Patents

Dattatrey Kokane holds a patent for the "Process for the preparation of Roflumilast." This invention relates to an improved method for synthesizing Roflumilast, a drug used in the treatment of chronic obstructive pulmonary disease (COPD). Additionally, the patent includes details about crystalline Form-I of Roflumilast, showcasing his innovative approach to pharmaceutical formulations. He has 1 patent to his name.

Career Highlights

Kokane is currently employed at Mylan Laboratories Limited, a global leader in generic and specialty pharmaceuticals. His role at Mylan allows him to apply his expertise in drug development and contribute to the advancement of healthcare solutions. His work is instrumental in ensuring that effective medications are accessible to patients worldwide.

Collaborations

Throughout his career, Dattatrey Kokane has collaborated with talented professionals in the industry, including Priyesh Vijaykar and Sushant Gharat. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Dattatrey Kokane's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in drug development. His patent for the preparation of Roflumilast highlights his commitment to improving healthcare solutions. Through his work at Mylan Laboratories Limited and collaborations with fellow professionals, he continues to make strides in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…